According to Portage Biotech's latest financial reports the company's current EPS (TTM) is -6,08 โฌ. In 2022 the company made an earnings per share (EPS) of -1,08 โฌ an increase over its 2021 EPS that were of -1,56 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -6,13 โฌ | 469.53% |
2022 | -1,08 โฌ | -30.99% |
2021 | -1,56 โฌ | 248.98% |
2020 | -0,45 โฌ | -10.45% |
2019 | -0,50 โฌ | -101.18% |
2018 | 42,27 โฌ | -1155.76% |
2017 | -4,00 โฌ | -143.89% |
2016 | 9,12 โฌ | -460.53% |
2015 | -2,53 โฌ | 29.28% |
2014 | -1,96 โฌ | -33.33% |
2013 | -2,94 โฌ | 35.17% |
2012 | -2,17 โฌ | -36.2% |
2011 | -3,40 โฌ | -58.05% |
2010 | -8,11 โฌ | 99.91% |
2009 | -4,06 โฌ | 497.14% |
2008 | -0,68 โฌ | 52.91% |
2007 | -0,44 โฌ | -50.68% |
2006 | -0,90 โฌ | -98.26% |
2005 | -51,78 โฌ | -522.45% |
2004 | 12,26 โฌ | 30.7% |
2003 | 9,38 โฌ | -130.44% |
2002 | -30,81 โฌ | -123.54% |
2001 | 130,88 โฌ |